ASH China Voice | Professor Zhao Yanmin: Precision Exploration in Hematopoietic Stem Cell Transplantation — From HLA Evolutionary Divergence Assessment to Post-Transplant Maintenance Strategies 

ASH China Voice | Professor Zhao Yanmin: Precision Exploration in Hematopoietic Stem Cell Transplantation — From HLA Evolutionary Divergence Assessment to Post-Transplant Maintenance Strategies 

At the recent Annual Meeting of the American Society of Hematology (ASH), the team led by Professor Huang He from the First Affiliated Hospital of Zhejiang University School of Medicine presented multiple innovative studies in the field of hematopoietic stem cell transplantation. These studies covered in-depth analyses of HLA evolutionary divergence (HED), post-transplant maintenance with epigenetic regulatory agents, and other cutting-edge topics, highlighting an integrated translational medicine strategy aimed at addressing key clinical challenges, comprehensively improving transplant outcomes, and enhancing long-term patient survival and quality of life. During the meeting, Hematology Frontier invited Professor Zhao Yanmin from the First Affiliated Hospital of Zhejiang University School of Medicine to systematically interpret the team’s core research achievements, elucidate their clinical value, and discuss future development directions, providing valuable insights for both academic research and clinical practice.
Voices from ASH China丨Professor Sun Ruijuan: Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Infant Acute Leukemia

Voices from ASH China丨Professor Sun Ruijuan: Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Infant Acute Leukemia

From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology (ASH) was grandly held in Orlando, USA. As the world’s largest and most influential international academic conference in the field of hematology, the ASH Annual Meeting attracts tens of thousands of experts and scholars each year to share the latest advances and breakthrough research. At this year’s meeting, a study led by Professor Sun Ruijuan from Lu Daopei Hospital was selected for poster presentation, focusing on the clinical efficacy of allogeneic hematopoietic stem cell transplantation in infant acute leukemia, providing important insights for the treatment of this challenging patient population. Hematology Frontier invited Professor Sun to share the details of this study for academic exchange.